Results show that the mRNA expression levels of HSP90AA1, NFKB2, PLAU, PTK2, and RECQL4 in patients with BC upregulated significantly, whereas the mRNA levels of CLU, JAK2, MAP3K5, and S100B downregulated sharply (p < .001, Figure 2A). This evidence concerns the gene CLU and breast cancer.